Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager (BiTE®) Antibody Constructs.

about

Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager (BiTE®) Antibody Constructs.

Item

http://www.wikidata.org/entity/Q54222576

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Antiviral Activity of HIV gp12 ...... r (BiTE®) Antibody Constructs.

@en

Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager

@nl

type

Item

label

Antiviral Activity of HIV gp12 ...... r (BiTE®) Antibody Constructs.

@en

Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager

@nl

altLabel

Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs

@en

prefLabel

Antiviral Activity of HIV gp12 ...... r (BiTE®) Antibody Constructs.

@en

Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager

@nl

P1476

Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs

@en

P2093

Christina K S Mueller

http://www.w3.org/2001/XMLSchema#string

Erika Schlaepfer

http://www.w3.org/2001/XMLSchema#string

Johannes Brozy

http://www.w3.org/2001/XMLSchema#string

Markus Muenz

http://www.w3.org/2001/XMLSchema#string

Mary-Aude Rochat

http://www.w3.org/2001/XMLSchema#string

Patrick A Baeuerle

http://www.w3.org/2001/XMLSchema#string

Peter Kufer

http://www.w3.org/2001/XMLSchema#string

Renier Myburgh

http://www.w3.org/2001/XMLSchema#string

Silvana K Rampini

http://www.w3.org/2001/XMLSchema#string

Tobias Raum

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

Engineering antibody-like inhibitors to prevent and treat HIV-1 infection.

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.

Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.

Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.

Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.

Spinoculation triggers dynamic actin and cofilin activity that facilitates HIV-1 infection of transformed and resting CD4 T cells.

P31

scholarly article

P356

10.1128/JVI.00491-18

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roberto F Speck

P577

2018-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29720517

http://www.w3.org/2001/XMLSchema#string

P932

6026749

http://www.w3.org/2001/XMLSchema#string